These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15119944)

  • 1. Regulation of signal transduction at M2 muscarinic receptor.
    Krejcí A; Michal P; Jakubík J; Rícný J; Dolezal V
    Physiol Res; 2004; 53 Suppl 1():S131-40. PubMed ID: 15119944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
    Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
    Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the novel positive allosteric modulator, LY2119620, at the muscarinic M(2) and M(4) receptors.
    Croy CH; Schober DA; Xiao H; Quets A; Christopoulos A; Felder CC
    Mol Pharmacol; 2014 Jul; 86(1):106-15. PubMed ID: 24807965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo.
    Schrage R; Holze J; Klöckner J; Balkow A; Klause AS; Schmitz AL; De Amici M; Kostenis E; Tränkle C; Holzgrabe U; Mohr K
    Biochem Pharmacol; 2014 Aug; 90(3):307-19. PubMed ID: 24863257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects.
    Valant C; Felder CC; Sexton PM; Christopoulos A
    Mol Pharmacol; 2012 Jan; 81(1):41-52. PubMed ID: 21989256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies.
    Birdsall NJ; Farries T; Gharagozloo P; Kobayashi S; Lazareno S; Sugimoto M
    Mol Pharmacol; 1999 Apr; 55(4):778-86. PubMed ID: 10101037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias.
    Gregory KJ; Hall NE; Tobin AB; Sexton PM; Christopoulos A
    J Biol Chem; 2010 Mar; 285(10):7459-74. PubMed ID: 20051519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors.
    May LT; Avlani VA; Langmead CJ; Herdon HJ; Wood MD; Sexton PM; Christopoulos A
    Mol Pharmacol; 2007 Aug; 72(2):463-76. PubMed ID: 17525129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of nematode G protein GOA-1 by the human muscarinic acetylcholine receptor M2 subtype. Functional coupling of G-protein-coupled receptor and G protein originated from evolutionarily distant animals.
    Minaba M; Ichiyama S; Kojima K; Ozaki M; Kato Y
    FEBS J; 2006 Dec; 273(24):5508-16. PubMed ID: 17087737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of muscarinic acetylcholine receptors via their allosteric binding sites.
    Jakubík J; Bacáková L; Lisá V; el-Fakahany EE; Tucek S
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8705-9. PubMed ID: 8710935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and quantification of allosteric modulation of endogenous m4 muscarinic acetylcholine receptor using impedance-based label-free technology in a neuronal cell line.
    Chen AN; Malone DT; Pabreja K; Sexton PM; Christopoulos A; Canals M
    J Biomol Screen; 2015 Jun; 20(5):646-54. PubMed ID: 25534830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structures of the M1 and M4 muscarinic acetylcholine receptors.
    Thal DM; Sun B; Feng D; Nawaratne V; Leach K; Felder CC; Bures MG; Evans DA; Weis WI; Bachhawat P; Kobilka TS; Sexton PM; Kobilka BK; Christopoulos A
    Nature; 2016 Mar; 531(7594):335-40. PubMed ID: 26958838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors.
    Lazareno S; Birdsall NJ
    Mol Pharmacol; 1995 Aug; 48(2):362-78. PubMed ID: 7651370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based discovery of selective positive allosteric modulators of antagonists for the M
    Korczynska M; Clark MJ; Valant C; Xu J; Moo EV; Albold S; Weiss DR; Torosyan H; Huang W; Kruse AC; Lyda BR; May LT; Baltos JA; Sexton PM; Kobilka BK; Christopoulos A; Shoichet BK; Sunahara RK
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2419-E2428. PubMed ID: 29453275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.
    Lazareno S; Dolezal V; Popham A; Birdsall NJ
    Mol Pharmacol; 2004 Jan; 65(1):257-66. PubMed ID: 14722259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M2 Subtype preferring dibenzodiazepinone-type muscarinic receptor ligands: Effect of chemical homo-dimerization on orthosteric (and allosteric?) binding.
    Keller M; Tränkle C; She X; Pegoli A; Bernhardt G; Buschauer A; Read RW
    Bioorg Med Chem; 2015 Jul; 23(14):3970-90. PubMed ID: 25650309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The M1 muscarinic receptor allosteric agonists AC-42 and 1-[1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one bind to a unique site distinct from the acetylcholine orthosteric site.
    Jacobson MA; Kreatsoulas C; Pascarella DM; O'Brien JA; Sur C
    Mol Pharmacol; 2010 Oct; 78(4):648-57. PubMed ID: 20660086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of transmembrane domain 3 in the actions of orthosteric, allosteric, and atypical agonists of the M4 muscarinic acetylcholine receptor.
    Leach K; Davey AE; Felder CC; Sexton PM; Christopoulos A
    Mol Pharmacol; 2011 May; 79(5):855-65. PubMed ID: 21300722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor.
    Steinfeld T; Mammen M; Smith JA; Wilson RD; Jasper JR
    Mol Pharmacol; 2007 Aug; 72(2):291-302. PubMed ID: 17478612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of an "Allosteric Site-Impaired" M
    Moo EV; Sexton PM; Christopoulos A; Valant C
    Mol Pharmacol; 2018 Nov; 94(5):1298-1309. PubMed ID: 30213802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.